Journal of the Korean Association of Oral and Maxillofacial Surgeons

  • 제49권5호
  • /
  • Pages.304-307
  • /
  • 2023
  • /
  • 2234-7550(pISSN)
  • /
  • 2234-5930(eISSN)
대한구강악안면외과학회 (The Korean Association of Oral and Maxillofacial Surgeons)
권호 표지
DOI QR코드

DOI QR Code

Late side effects of bleomycin injection into the lower lip mucosa of a nine-year-old patient with venous malformation

  • Kezia Rachellea Mustakim (Department of Oral and Maxillofacial Surgery, Dental Research Institute, School of Dentistry, Seoul National University) ;
  • Soung Min Kim (Department of Oral and Maxillofacial Surgery, Dental Research Institute, School of Dentistry, Seoul National University)
  • 투고 : 2023.01.28
  • 심사 : 2023.02.28
  • 발행 : 2023.10.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Venous malformation (VM) is a benign lesion of blood vessels caused by an error in vascular morphogenesis during the embryologic phase. This entity mostly affects the head and neck region, including the lips, tongue, buccal mucosa, gingiva, or palate. VM may cause functional and aesthetic impairments. The anatomical structure and shape of the lips provide an important aesthetic accent for an individual. Therefore, management of VM in the lip area without postoperative defects or scarring is challenging. In this brief communication article, we present a conservative approach to lip VM in a nine-year-old boy using a bleomycin injection that had good aesthetic and functional outcomes. Injection of 2 mL of 1/10 of 15 mg bleomycin in a saline dilution into the lip mucosa may present a drug reaction as a white plaque and reddish owl eye lesion that takes up to three weeks to resolve without a scar. It is important to recognize the characteristics and self-limiting nature of postoperative bleomycin complications to avoid unnecessary treatment.

키워드

과제정보

This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. 2022R1F1A1069624).

참고문헌

  1. Couto DAF, Ito FA, Lima HG, Novais JD, Novais JB, Dallazen E, et al. Sclerotherapy for extensive vascular malformation in the tongue. J Craniofac Surg 2019;30:e796-9. https://doi.org/10.1097/scs.0000000000005788
  2. Zeevi I, Chaushu G, Alterman M, Chaushu L. Sclerotherapy of vascular malformations in the oral cavity-minimizing postoperative morbidity. Medicina (Kaunas) 2020;56:254. https://doi.org/10.3390/medicina56050254
  3. Bajpai H, Bajpai S. Comparative analysis of intralesional sclerotherapy with sodium tetradecyl sulfate versus bleomycin in the management of low flow craniofacial soft tissue vascular lesions. J Maxillofac Oral Surg 2012;11:13-20. https://doi.org/10.1007/s12663-011-0325-7
  4. Min HG, Kim SG, Oh JS, You JS. Sclerotherapy using 1% sodium tetradecyl sulfate to treat a vascular malformation: a report of two cases. J Korean Assoc Oral Maxillofac Surg 2015;41:322-6. https://doi.org/10.5125/jkaoms.2015.41.6.322
  5. Berenguer B, Burrows PE, Zurakowski D, Mulliken JB. Sclerotherapy of craniofacial venous malformations: complications and results. Plast Reconstr Surg 1999;104:1-11; discussion 12-5.
  6. Song D, Guo L, Sheng H, Li J, Wang L, Wu C, et al. DSA-guided percutaneous sclerotherapy for children with oropharyngeal low-flow venous malformation. Exp Ther Med 2020;19:3405-10. https://doi.org/10.3892/etm.2020.8581